Navigation Links
Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
Date:3/19/2008

Companies to Evenly Divide Value of TAP

OSAKA, Japan, and ABBOTT PARK, Ill., March 19 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited and Abbott have entered into an agreement to conclude their TAP Pharmaceutical Products Inc. (TAP) joint venture. The companies expect the transaction to close within 30-60 days.

Under terms of the agreement, the companies will evenly divide the value of the joint venture. Abbott receives rights to the oncology treatment, Lupron, including the commercial organization supporting that franchise, and will receive payments based on TAP's other current and certain future products. Takeda receives the rights to the product Prevacid, all the remaining TAP commercial and support organizations, and the rights to TAP's pipeline.

Abbott expects the transaction to be neutral to 2008 earnings per share. Takeda expects that this agreement will have no impact to its consolidated financial results for the current fiscal year.

The TAP joint venture was created by Takeda and Abbott in 1977 and has been one of the most successful joint ventures in the history of American business. In 2007, TAP had revenues of $3.1 billion from its two currently marketed products, Prevacid and Lupron. Additionally, TAP has two new drug applications under review at the U.S. Food and Drug Administration (FDA).

"I want to take this opportunity to thank our partners at Abbott and the many people who helped make TAP a successful company in its more than 30 years of existence," said Yasuchika Hasegawa, president, Takeda Pharmaceutical Company Limited. "With this agreement Takeda combines two successful organizations and creates a top 15 pharmaceutical company with more than 5,000 employees in the United States. This size and talent base creates a tremendous platform for continued growth in the world's largest pharmaceutical market, which plays a significant role in Takeda's ongoing global growth."

"
'/>"/>

SOURCE Abbott; Takeda Pharmaceutical Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... In a world enveloped in technological ... lessened, and due to the intrusion of cell ... has eroded. According to Web MD, one in ... http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high number lowers ... amount, leading not only to dissatisfied employers, but ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. ... to acquire a second language, new research suggests. But anyone ... gain a brain boost, the small study finds. ... study co-author Ping Li, co-director of the Center for Brain, ... more interesting, Li said, that "the brain networks of the ...
(Date:11/27/2014)... The founders of VIM & VIGR, a company ... compression socks, are proud to announce the debut of their ... Pressure (TM) knitting technology that is designed to increase the ... to adding flair and style to a product that has ... eye of a writer at The New York Times ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VogueQueen.com is ... items for ladies across the world. As the premier ... accessories, VogueQueen.com is proud to release a huge selection ... high quality outfits, it is also providing many beautiful ... VogueQueen prom gowns at discounted prices. , “VogueQueen.com ...
(Date:11/27/2014)... Texas (PRWEB) November 27, 2014 ... report on Global Insulin industry. For an overview ... definition, classification, application, industry chain structure, industry overview, ... on global Insulin industry covers information on ... process, product cost structure and much more. ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... Feb. 3 Noticing a few extra hairs in your,comb ... conceal areas of,thinning hair rather than a fashion choice? Are ... growth? If you answered,yes to any of these questions, you ... of hair loss. But to whom should you turn for ...
... importance of physical activities to improve balance , , SUNDAY, Feb. ... one in three seniors over age 65, and almost one ... this year -- in some cases, leading to serious disability ... their balance and reduce their risk of falls are expected ...
... patient safety enhancements to dramatically reduce errors and improve ... obstetrical care. , Edmund F. Funai, M.D., associate ... Sciences at Yale, will present preliminary results from this ... Meeting on February 2 in Dallas, Texas. , An ...
... February is American Heart Month, a,time when experts say ... to,reduce risk for heart disease. Here,s more on how ... but just eat the right kind for good heart ... Association of Margarine,Manufacturers at: http://media.medialink.com/WebNR.aspx?story=34443 , Registered ...
... potential for patients with specific gene mutations, researchers find ... sorafenib shows promise in the treatment of people with ... U.S. researchers. , Previous research has shown that sorafenib ... -- is effective against acute myeloid leukemia cells that ...
... LOUISVILLE, Ky., Feb. 1 Ventas, Inc. ... it has completed the,sale of 4,485,000 shares of ... registration statement. The amount includes 585,000 shares,of common ... of the,underwriter,s overallotment option. The Company received net ...
Cached Medicine News:Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 2Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 3Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 4Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 5Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 6Health News:Toll-Free Hotline to Help Seniors Avoid Falls 2Health News:New strategy helps reduce errors in obstetrical care 2Health News:Sorafenib Slows Growth of Some Leukemias 2Health News:Ventas Completes Previously Announced Sale of Common Stock 2Health News:Ventas Completes Previously Announced Sale of Common Stock 3Health News:Ventas Completes Previously Announced Sale of Common Stock 4
(Date:11/26/2014)... , Nov. 26, 2014  Cohen, Placitella & ... of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" ... the period from January 31, 2011 through November ... Nymox and certain of its officers and directors ... violation of Sections 10(b) and 20(a) of the ...
(Date:11/26/2014)... 2014   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... CEO of Regulus, will present a company overview at ... at the New York Palace Hotel on Wednesday, December ... be webcast at the time of the presentation and ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Calif., May 9, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... the fiscal quarter ended March 31, 2011, and provided ... ended March 31, 2011 and 2010, as reported in ... States, was $8.4 million and $13.4 million, respectively.  At ...
... Inc. (OTC: LPTN), the category leader in bioactive-lipid-targeted therapeutics, ... available for on-demand viewing. LINK: www.retailinvestorconferences.com ... button. Lpath, Inc.,s presentation will be available ... from the "virtual trade booth" for the next three ...
Cached Medicine Technology:Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 7Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 8Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 9Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: